COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

First U.S. Case Since FDA-Approval, New Magnetic Device for Heartburn

 

April 10, 2012  |  

On Monday, April 9, Santiago Horgan, MD, chief of minimally invasive surgery at UC San Diego Health System implanted the new FDA-approved LINX device in a 29-year old patient suffering from gastroesophageal reflux disease (GERD), a chronic digestive disease that can lead to severe inflammation, stricture, Barrett’s esophagus and esophageal cancer.

 

 LINX surgery - Horgan

Santiago Horgan, MD, implants first LINX device since FDA approval.
“The multi-center clinical trial results clearly showed that the magnetic device is highly effective in treating GERD and the painful burning that results from this progressive condition,” said Horgan, an international expert in treating esophageal disease. “Unlike drugs that suppress stomach acids, this flexible device corrects the anatomy and immediately addresses the actual source of reflux.”

 

The LINX system is composed of a series of titanium beads, each with a magnetic core, that are connected to form a ring shape. It is implanted at the lower esophageal sphincter (LES), a circular band of muscle that closes the last few centimeters of the esophagus and prevents the backward flow of stomach contents.

 

 GERD illustration

The LINX device is designed to prevent acid reflux but allow for digestion.
“This device has changed my life,” said Gina Brickell, one of the first recipients of the LINX device. “I suffered from GERD for years. Now I can eat what I want, when I want, and where I want.”

 

The FDA approved the LINX Reflux Management System in March 2012. Horgan and his surgical team have implanted more than 20 of the devices during the clinical trial phase, representing the most surgeries in the second phase of procedures that led to FDA approval.

The LINX device is an option for patients who do not respond to dietary and lifestyle measures. The device can be placed during a 20-30 minute minimally invasive surgery. Patients may leave the hospital the same day after brief observation.

 

LINX-YouTube-Horgan

Click on the above image to watch video of Horgan discussing LINX technique for GERD.

Magnetic Resonance Imaging (MRI) tests are prohibited if you have received the LINX Reflux Management System.

 

The LINX Reflux Management System is manufactured by Torax Medical Inc. in St. Paul, Minn.

To learn more about eligibility for the LINX device at UC San Diego Health System, please call 619-471-0447.

# # #

Media Contact: Jackie Carr, 619-543-6163, jcarr@ucsd.edu




Media Contact

Share This Article


Related News

7/28/2021
Obesity is a major public health issue among Latinos, and a risk factor for Alzheimer’s disease. But in a new study, researchers at UC San Diego report that cardiometabolic abnormalities, such as hype ...
7/28/2021
Cardiovascular physicians with UC San Diego Health have joined an international clinical trial utilizing a new Extravascular Implantable Cardioverter-Defibrillator (EV ICD) system to help treat sudden ...
7/26/2021
UC San Diego Health, the region’s only academic health system, is ranked #1 in San Diego and #5 in California, placing it among the nation’s best hospitals, according to the 2021-2022 U.S. News & Worl ...
7/23/2021
Senate President Pro Tempore Toni Atkins visited UC San Diego Medical Center today to recognize a $30 million allocation in the 2021-2022 California state budget that will support the redevelopment of ...



Follow Us